Eloxx Pharmaceuticals OverviewEloxx Pharmaceuticals EBIT
EBIT (Earnings Before Interest and Taxes) analysis for ELOX.
Quarterly EBIT
-$3.80M
As of Mar 31, 2026
Annual EBIT (TTM)
-$17.05M
↑ 49.95% YoY
Trailing 12 months ending Mar 31, 2026
Eloxx Pharmaceuticals OverviewEBIT (Earnings Before Interest and Taxes) analysis for ELOX.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026